Clinical trial · Observational
Radiation Impact on Thromboembolic Events
Radiation Therapy and Venous Thromboembolic Events
NCT02696447CI-TRIAL-00043066RITcompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the present study is to determine the frequency and to identify main risk factors for venous thromboembolism of venous thromboembolic complications in a population of cancer patients treated with a curative intent by ionizing radiation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Malignant Neoplasm | Malignant Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Biomarkers assays | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Cancer treated by radiotherapy
- description
- Patient with a solid cancer (all locations) treated with radiation therapy and/or brachytherapy as curative intent
- interventionNames
- Biological: Biomarkers assays
Primary outcomes (1)
- measure
- Venous Thromboembolism event
- timeFrame
- 6 months
- description
- All venous thromboembolism, whether symptomatic or discovered incidentally, objectified (CT angiography, lung scintigraphy, venous Doppler) between J1 of radiation treatment, up to 6 months following discontinuation of radiation treatment
Secondary outcomes (5)
- measure
- Dosage of D-dimer
- timeFrame
- 6 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * patient with a solid cancer (all locations) treated with radiation therapy and / or brachytherapy as curative intent * to be 18 Exclusion Criteria: * Patient with metastatic cancer, * Patients whose follow-up at 6 months is not possible * Patient receiving an anti-coagulative medication (curative doses) * Pregnant or breastfeeding women, * Person under protection of justice or unable to give consent
References
Publications (1)
- DERIVEDDaguenet E, Maison M, Tinquaut F, Giroux EA, Bertoletti L, Suchaud JP, Rancoule C, Guy JB, Magne N. Venous thromboembolism and radiation therapy: The final radiation-induced thrombosis study analysis. Cancer Med. 2022 Apr;11(8):1753-1762. doi: 10.1002/cam4.4559. Epub 2022 Feb 24. PMID 35199492